New 1,1,3-trioxo-2H,4H-thieno[3,4-e]thiadiazine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase

Myriam Witvrouw; Ma Esther Arranz; Christophe Pannecouque; Ruben Declercq; Heidi Jonckheere; J.C.C. Schmit; Anne‐Mieke Vandamme; Juan H. Ayala; Jan Desmyter; Robert Esnouf; Luc Van Meervelt; Jan Balzarini; Sonia Vega; De Clercq Erik

doi:10.1016/s0166-3542(97)83186-5

Back

Shared by

De Clercq Erik

KU Leuven

New 1,1,3-trioxo-2H,4H-thieno[3,4-e]thiadiazine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase

Article 1997 en

Authors

MW
Myriam Witvrouw
MA
Ma Esther Arranz
CP
Christophe Pannecouque

Related publications

Article1999

Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors

Ma Esther Arranz, Juan Antonio Díaz‐Pendón, Simon T. Ingate, Myriam Witvrouw, Christophe Pannecouque, Jan Balzarini, De Clercq Erik, Salvador Vega

Article2003

Synthesis and Anti-HIV Activity Studies of a Novel Class of Non-nucleoside Reverse Transcriptase Inhibitors: 2,4-Disubstituted-1,1,3-trioxo-2H,4H- thieno[3,4-e][1,2,4]thiadiazine (TTD) Analogues

Xinyong Liu, Marı́a Teresa Molina, S. VEGA, De Clercq Erik, Christophe Pannecouque, M. Wirvrouw

Article1998

Novel 1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine Derivatives as Non-Nucleoside Reverse Transcriptase Inhibitors That Inhibit Human Immunodeficiency Virus Type 1 Replication

Esther Arranz, Juan Antonio Díaz‐Pendón, Simon T. Ingate, Myriam Witvrouw, Christophe Pannecouque, Jan Balzarini, De Clercq Erik, Salvador Vega

Article1992

Potent and highly selective HIV-1 specific inhibition by a new series of alfa-anilino phenyl acetamide (alfa-APA) derivatives targeted at HIV-1 reverse transcriptase

Rudi Pauwels, Koen Andries, Zeger Debyser, Peter Van Daele, Dominique Schols, Paul Stoffels, Anne‐Mieke Vandamme, R. Woestenborghs, K. de Vreese, C. G. M. JANSSEN, Jozef Anné, Jan Desmyter, J. Heykants, M. Janssen, De Clercq Erik, Paul A. J. Janssen

Article1993

HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase

De Clercq Erik

New 1,1,3-trioxo-2H,4H-thieno[3,4-e]thiadiazine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase

Discussion(0)

Related publications

Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors

Synthesis and Anti-HIV Activity Studies of a Novel Class of Non-nucleoside Reverse Transcriptase Inhibitors: 2,4-Disubstituted-1,1,3-trioxo-2H,4H- thieno[3,4-e][1,2,4]thiadiazine (TTD) Analogues

Novel 1,1,3-Trioxo-2<i>H</i>,4<i>H</i>-thieno[3,4-<i>e</i>][1,2,4]thiadiazine Derivatives as Non-Nucleoside Reverse Transcriptase Inhibitors That Inhibit Human Immunodeficiency Virus Type 1 Replication

Potent and highly selective HIV-1 specific inhibition by a new series of alfa-anilino phenyl acetamide (alfa-APA) derivatives targeted at HIV-1 reverse transcriptase

HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase